Leadership Overview
Biotronik has 4 executives leading key functions including finance, medical affairs, neuromodulation, and overall leadership.
Driven by innovation, Biotronik provides complete solutions for diagnosis, treatment, and therapy support in cardiac rhythm management, electrophysiology, and vascular intervention, impacting global healthcare.
Driven by innovation, Biotronik provides complete solutions for diagnosis, treatment, and therapy support in cardiac rhythm management, electrophysiology, and vascular intervention, impacting global healthcare.
Leadership Roles at Biotronik
James Felsted - Vice President, Finance & Chief Financial Officer, Administration, Region (US)
James Felsted, the Vice President, Finance & Chief Financial Officer, Administration, Region (US) at Biotronik, directs financial strategy and administration for the US region. Overseeing fiscal operations, Felsted ensures robust financial planning, accurate reporting, and efficient resource allocation to support Biotronik's mission in cardiac rhythm management and vascular intervention. This leadership position involves managing budgets, optimizing financial performance, and driving administrative efficiencies across the organization. By maintaining strong financial controls and fostering strategic partnerships, James Felsted underpins the company's growth and operational stability. The scope of this role extends to ensuring compliance with financial regulations and contributing to the overall strategic direction of Biotronik's US operations, directly impacting the company's ability to deliver advanced medical technologies.
Todd Langevin - President Neuromodulation
Todd Langevin, the President Neuromodulation at Biotronik, spearheads the strategic direction and operational execution for the neuromodulation division. Langevin directs the expansion of Biotronik's portfolio in this specialized area, focusing on innovative solutions that address neurological conditions. This leadership role encompasses driving market penetration, fostering product development pipelines, and ensuring seamless integration of neuromodulation technologies with the company's broader offerings in cardiac rhythm management and vascular intervention. Todd Langevin collaborates with cross-functional teams to achieve ambitious growth targets and enhance patient outcomes through advanced therapeutic approaches. The focus remains on building a strong market presence and delivering cutting-edge devices that redefine treatment possibilities within the field of neuromodulation.
Ryan Walters - President
Ryan Walters, the President at Biotronik, provides overarching leadership and strategic vision for the company's global operations. Walters directs Biotronik's mission to deliver complete solutions for diagnosis, treatment, and therapy support across cardiac rhythm management, electrophysiology, and vascular intervention. This executive position involves guiding key business initiatives, fostering a culture of innovation, and ensuring operational excellence throughout the organization. Ryan Walters works closely with divisional leaders to drive market growth, enhance product development, and maintain Biotronik's commitment to improving patient lives worldwide. The strategic oversight from Walters is fundamental to the company's sustained success and its position as a leader in advanced medical technology.
David Hayes - Chief Medical Officer
David Hayes, the Chief Medical Officer at Biotronik, guides the company's medical strategy and clinical affairs. Hayes oversees the development and implementation of clinical research programs, ensuring that Biotronik's diagnostic, treatment, and therapy support solutions align with the highest medical standards and patient needs. This critical role involves close collaboration with R&D, marketing, and regulatory teams to translate clinical insights into product innovation for cardiac rhythm management and electrophysiology. David Hayes champions evidence-based medicine, driving the generation of robust clinical data that supports the efficacy and safety of Biotronik's technologies. The medical leadership provided by Hayes is essential for maintaining Biotronik's reputation as a trusted provider of advanced cardiovascular solutions and for expanding its impact in vascular intervention.
Explore Leadership Teams in Manufacturing
National Dentex Labs provides dental prosthetics, restorative dental products, and other dental services. Their products and services include dentures and partials, crowns, implants, appliances, and orthodontics. The company is headquartered in Palm Beach Gardens, Florida, and was founded in 1982.
Company Leadership FB
JB
MM
Headquartered in North Carolina, Medical Manufacturing Technologies (MMT) offers manufacturing-as-a-service that brings together applications expertise, technical solutions, and aftermarket support to revolutionize medical device manufacturing.
Company Leadership VS
RS
TS
Founded in 2000 and headquartered in Port Washington, New York, Drive DeVilbiss Healthcare is a company that manufactures a line of durable medical equipment including mobility products, beds, bariatric products, wheelchairs, and more.
Company Leadership DL
EM
RA
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Company Leadership JR
MM
Frequently Asked Questions Regarding Biotronik Top Executives and Leadership Team
